Literature DB >> 22689701

Validity of a brief computerized cognitive screening test in dementia.

Dustin Hammers1, Elizabeth Spurgeon, Kelly Ryan, Carol Persad, Nancy Barbas, Judith Heidebrink, David Darby, Bruno Giordani.   

Abstract

BACKGROUND: While preliminary evidence supports the criterion validity of the CogState computerized brief battery in mild cognitive impairment (MCI) and Alzheimer disease (AD), definitive validation studies examining a wider range of dementia-related disorders relative to conventional neuropsychological techniques are necessary.
METHODS: Participants satisfying clinical consensus criteria for dementia (AD, n = 37; frontotemporal dementia, n = 7; and dementia with Lewy bodies, n = 5), MCI (n = 16), and the healthy controls (n = 22) were administered a battery of brief neuropsychological and select computerized (CogState) cognitive tests. The battery, administered through the University of Michigan Alzheimer's Disease Research Center, included measures of processing speed, attention, working memory, and learning.
RESULTS: CogState and standard neuropsychological task scores were significantly lower for dementia participants than that of the nondementia groups (P < .05), with a single CogState test distinguishing control from MCI participants, but minimal differentiation existing between dementias using the CogState. Correlations were modest between conventional and computerized test scores, covering matching domains and mostly reflecting the multidimensional nature of cognitive paradigms.
CONCLUSIONS: Results support the clinical validity of this brief computerized screening battery when used in established dementias, but not to differentiate between various dementias, and suggest that the select CogState battery's effectiveness in identifying MCI from controls was not as strong as identifying specific dementias.

Entities:  

Mesh:

Year:  2012        PMID: 22689701     DOI: 10.1177/0891988712447894

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  31 in total

1.  Posttraumatic stress disorder symptoms and cognitive function in a large cohort of middle-aged women.

Authors:  Jennifer A Sumner; Kaitlin Hagan; Fran Grodstein; Andrea L Roberts; Brian Harel; Karestan C Koenen
Journal:  Depress Anxiety       Date:  2017-01-10       Impact factor: 6.505

2.  Prospective computerized monitoring of cognitive functioning before and after blood and marrow transplantation.

Authors:  K L Votruba; F Hoodin; B Giordani; R Kentor; D R Couriel; C L Kitko
Journal:  Bone Marrow Transplant       Date:  2017-06-12       Impact factor: 5.483

3.  Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.

Authors:  Annie M Racine; Lindsay R Clark; Sara E Berman; Rebecca L Koscik; Kimberly D Mueller; Derek Norton; Christopher R Nicholas; Kaj Blennow; Henrik Zetterberg; Bruno Jedynak; Murat Bilgel; Cynthia M Carlsson; Bradley T Christian; Sanjay Asthana; Sterling C Johnson
Journal:  J Alzheimers Dis       Date:  2016-10-18       Impact factor: 4.472

4.  Performance of the CogState computerized battery in the Mayo Clinic Study on Aging.

Authors:  Michelle M Mielke; Mary M Machulda; Clinton E Hagen; Kelly K Edwards; Rosebud O Roberts; V Shane Pankratz; David S Knopman; Clifford R Jack; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2015-04-06       Impact factor: 21.566

5.  Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries.

Authors:  R F Buckley; K P Sparks; K V Papp; M Dekhtyar; C Martin; S Burnham; R A Sperling; D M Rentz
Journal:  J Prev Alzheimers Dis       Date:  2017

6.  Cognitive functioning following stabilisation from first episode mania.

Authors:  Rothanthi Daglas; Kelly Allott; Murat Yücel; Lisa P Henry; Craig A Macneil; Melissa K Hasty; Michael Berk; Sue M Cotton
Journal:  Int J Bipolar Disord       Date:  2017-12-18

Review 7.  Applications of technology in neuropsychological assessment.

Authors:  Carolyn M Parsey; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2013-09-16       Impact factor: 3.535

8.  Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors.

Authors:  Erika Roddy; Katherine Sear; Erin Felton; Benita Tamrazi; Karen Gauvain; Joseph Torkildson; Benedict Del Buono; David Samuel; Daphne A Haas-Kogan; Josephine Chen; Robert E Goldsby; Anuradha Banerjee; Janine M Lupo; Annette M Molinaro; Heather J Fullerton; Sabine Mueller
Journal:  Neuro Oncol       Date:  2016-08-18       Impact factor: 12.300

9.  Exercise, sedentary pastimes, and cognitive performance in healthy older adults.

Authors:  Susanne Inez Steinberg; Mary Dupuis Sammel; Brian Tal Harel; Adrian Schembri; Christopher Policastro; Hillary R Bogner; Selamawit Negash; Steven Edward Arnold
Journal:  Am J Alzheimers Dis Other Demen       Date:  2014-08-05       Impact factor: 2.035

10.  Cognitive Function and Quality of Life in Vorinostat-Treated Patients after Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplantation.

Authors:  Flora Hoodin; Leah LaLonde; Josh Errickson; Kristen Votruba; Rachel Kentor; Erin Gatza; Pavan Reddy; Sung Won Choi
Journal:  Biol Blood Marrow Transplant       Date:  2018-09-20       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.